Bactolife raised €30m Series B led by Cross Border Impact Ventures and EIFO, joined by Novo Holdings, family office Athos and the Gates Foundation

Biotech Health services Manufacturing

Investments

27 December 2025

Bactolife (company)

Biotech Health services Manufacturing

Total investments received (USD): 76.25m

Round value (USD): 34.68m

Round investors: Athos Service Novo A/S Bill & Melinda Gates Foundation Trust Cross Border Impact Ventures EIFO

Industry: Biotech Health services Manufacturing

AI (big data) Competitive Intelligence CRM Software Services

Investments 05 April 2026

Biotech Food Industry Manufacturing

Investments 05 April 2026

Biotech Health services

Investments 04 April 2026

Cleantech Electronics Energy Hardware Manufacturing

Investments 01 April 2026

AI (big data) Biotech Competitive Intelligence Health services Software Services

Investments 02 March 2026